Is JCR Pharmaceuticals Co stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, JCR Pharmaceuticals Co pays dividends. Last time was Sunday 1st of June 2025 where the investors holding the stock on Friday 28th of March 2025 were paid $0.06433 per share. Over the last 9 times between 2021 and 2025, JCR Pharmaceuticals Co has paid $0.66752026 with an average of $0.07 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for JCR Pharmaceuticals Co 10 years ago, but if you had invested on Friday 29th of January 2021 when the price was $33.85, you would have made a loss of $-29.28 per share or -86.50%
No, the average daily trading liquidity for JCR Pharmaceuticals Co is $7 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
JCR Pharmaceuticals Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.12, the company's ability to pay off the debt is normal. JCR Pharmaceuticals Co has a good net profit margin of 10.19% and should have high tolerances against inflation.
We have calculated the inflation risk for JCR Pharmaceuticals Co to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.